Evaluation of Links Between High-Density Lipoprotein Genetics, Functionality, and Aortic Valve Stenosis Risk in Humans

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/ATVBAHA.113.302730PMID 24334872
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improvement of aortic valve stenosis by ApoA‐I mimetic therapy is associated with decreased aortic root and valve remodelling in mice

  2013cited by this paper
• A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferase.

  2013cited by this paper
• Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks

  2013cited by this paper
• Genetic associations with valvular calcification and aortic stenosis.

  2013cited by this paper
• An integrated map of genetic variation from 1,092 human genomes

  2012cited by this paper
• Degenerative calcific aortic stenosis: a natural history

  2012cited by this paper
• Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.

  2012cited by this paper
• Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

  2012cited by this paper
• The Metabochip, a Custom Genotyping Array for Genetic Studies of Metabolic, Cardiovascular, and Anthropometric Traits

  2012cited by this paper
• Role of Cellular Cholesterol Metabolism in Vascular Cell Calcification*

  2011cited by this paper
• Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

  2011cited by this paper
• Replication of genetic association studies in aortic stenosis in adults.

  2011cited by this paper
• High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification.

  2011cited by this paper
• Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease

  2010cited by this paper
• The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

  2010cited by this paper
• Age-related differences in the pathogenesis of calcific aortic stenosis: the potential role of resistin.

  2010cited by this paper
• High pre-beta1 HDL concentrations and low lecithin: cholesterol acyltransferase activities are strong positive risk markers for ischemic heart disease and independent of HDL-cholesterol.

  2010cited by this paper
• An agonist of liver X receptor slows valvular disease in a hypercholesterolemia mouse model.

  2010cited by this paper
• Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model.

  2010influential reference
• A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies

  2009cited by this paper
• Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression

  2009cited by this paper
• [Smoking, increase in plasma lipoprotein (a) and triglycerides, as well as decrease in plasma HDL-cholesterol concentrations seem to be linked with aortic valve stenosis and its progression].

  2009cited by this paper
• Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

  2008cited by this paper
• Abstract 6143: Regression of Aortic Valve Stenosis by ApoA-I Mimetic Peptide Infusions in Rabbits

  2008cited by this paper
• Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France

  2006cited by this paper
• Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

  2006cited by this paper
• Mutations in NOTCH1 cause aortic valve disease

  2005cited by this paper
• Heterogeneous geographic distribution of patients with aortic valve stenosis: arguments for new aetiological hypothesis

  2005cited by this paper
• Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.

  2003cited by this paper
• High-Density Lipoprotein Regulates Calcification of Vascular Cells

  2002cited by this paper
• Clinical Factors Associated With Calcific Aortic Valve Disease

  1997cited by this paper
• Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.

  1997cited by this paper
• Temporal changes in the causes of aortic stenosis: a surgical pathologic study of 646 cases.

  1987cited by this paper

• Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?

  2025cites this paper
• Measures of high-density lipoprotein function in men and women with severe aortic stenosis

  2022cites this paper
• High-Density Lipoprotein and Long-Term Incidence and Progression of Aortic Valve Calcification: The Multi-Ethnic Study of Atherosclerosis

  2022cites this paper
• Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis

  2021cites this paper
• miR-33-5p knockdown attenuates abdominal aortic aneurysm progression via promoting target adenosine triphosphate-binding cassette transporter A1 expression and activating the PI3K/Akt signaling pathway

  2020cites this paper
• High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.

  2020cites this paper
• HDL-C Role in Acquired Aortic Valve Stenosis Patients and Its Relationship with Oxidative Stress

  2019cites this paper
• Oxidized HDL, as a Novel Biomarker for Calcific Aortic Valve Disease, Promotes the Calcification of Aortic Valve Interstitial Cells

  2019cites this paper
• Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.

  2019cites this paper
• Longitudinal Changes in Cholesterol Efflux Capacities in Patients With Coronary Artery Disease Undergoing Lifestyle Modification Therapy

  2018cites this paper
• Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.

  2018cites this paper
• Sex-related Differences in Calcific Aortic Valve Stenosis: Pathophysiology, Epidemiology, Etiology, Diagnosis, Presentation, and Outcomes

  2018cites this paper
• Impact d'interventions non pharmacologiques sur les biomarqueurs émergents du risque cardiovasculaire : fonctionnalité des HDL et PCSK9

  2018cites this paper
• Impact d'une prise en charge multidisciplinaire sur la fonctionnalité des particules HDL d'adolescents présentant un surplus pondéral

  2018cites this paper
• Improving HDL Functions - A New Version of The Quest of SANCGREAL?

  2018cites this paper
• Biomarkers of Calcific Aortic Valve Disease

  2017cites this paper
• Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration

  2017cites this paper
• Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact

  2017cites this paper
• Hypothesis: New PCSK9 Inhibitors May Impact Calcific Aortic Valve Disease.

  2017cites this paper
• Functionality of High-Density Lipoprotein as Antiatherosclerotic Therapeutic Target.

  2016cites this paper
• Genome-Wide DNA Methylation Analysis and Epigenetic Variations Associated with Congenital Aortic Valve Stenosis (AVS)

  2016cites this paper
• High-Density Lipoprotein: An Ambiguous Therapeutic Target in Atherosclerosis and Cardiovascular Disease

  2016influential citation
• Role of serum high density lipoprotein levels and functions in calcific aortic valve stenosis progression.

  2015cites this paper
• Évolution échocardiographique et prédicteurs de progression de la sténose valvulaire aortique

  2015cites this paper
• Genomics to elucidate the molecular basis of calcific aortic valve disease

  2015cites this paper
• Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve

  2015cites this paper
• HDL and cardiovascular risk: is cholesterol in particle subclasses relevant?

  2015cites this paper
• The association of APOC4 polymorphisms with premature coronary artery disease in a Chinese Han population

  2015cites this paper
• Basic mechanisms of calcific aortic valve disease.

  2014cites this paper
• Genetic predisposition to calcific aortic stenosis and mitral annular calcification

  2014cites this paper
• Molecular biology of calcific aortic valve disease: towards new pharmacological therapies

  2014cites this paper
• Advances in the treatment of aortic valve disease: is it time for companion diagnostics?

  2014cites this paper